1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
10
AuAg Gold Rush A
Fee
1.40%
ISIN
SE0020677946
Holdings
21
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with AuAg Gold Rush, we have 23 holdings where Franco-Nevada is the largest holding (8.21), followed by Osisko Gold Royalties (8.07) and Royal Gold (7.88).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and AuAg Gold Rush.
| UBS Lux Equity Fund Biotech USD | AuAg Gold Rush |
|---|---|
|
10.04 % |
 8.21 % |
|
9.9 % |
8.07 % |
|
9.21 % |
 7.88 % |
|
6.54 % |
7.52 % |
|
5.52 % |
4.11 % |
|
4.66 % |
4.11 % |
|
4.32 % |
4.05 % |
|
4.13 % |
4.02 % |
|
3.75 % |
3.96 % |
|
3.28 % |
 3.95 % |
| - |
3.92 % |
| - |
3.9 % |
| - |
3.87 % |
| - |
3.84 % |
| - |
3.82 % |
| - |
 3.79 % |
| - |
3.64 % |
| - |
3.61 % |
| - |
 2.3 % |
| - |
2.24 % |
| - |
2.17 % |
The list of fund holdings was last updated on April 17, 2025.
